Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Buy
1,673
+1,428
+583% +$167K 0.08% 91
2026
Q1
$29.5K Buy
245
+24
+11% +$2.77K 0.01% 288
2025
Q4
$23.3K Buy
221
+111
+101% +$10.4K 0.01% 358
2025
Q3
$9.23K Buy
110
+14
+15% +$1.15K ﹤0.01% 538
2025
Q2
$7.6K Sell
96
-215
-69% -$17.1K ﹤0.01% 553
2025
Q1
$27.9K Buy
311
+99
+47% +$9.24K 0.02% 256
2024
Q4
$21.1K Sell
212
-87
-29% -$8.97K 0.01% 300
2024
Q3
$34K Sell
299
-157
-34% -$18.7K 0.02% 215
2024
Q2
$56.5K Hold
456
0.04% 142
2024
Q1
$60.2K Sell
456
-7
-2% -$863 0.04% 141
2023
Q4
$50.5K Buy
+463
New +$48.1K 0.04% 138

Other funds holding MRK

WealthCollab's MRK Position: Q2 2026 in Review

WealthCollab increased its Merck (MRK) stake by 583% in Q2 2026, buying an estimated $167K and bringing the position to 1,673 shares worth $215K. The position accounts for 0.08% of the portfolio, ranked #91.

WealthCollab first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • WealthCollab held 1,673 shares of Merck worth $215K as of Q2 2026.
  • WealthCollab bought 1,428 Merck shares in Q2 2026, an estimated $167K.
  • Merck made up 0.08% of WealthCollab's portfolio in Q2 2026, its #91 holding.
  • WealthCollab first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.